Masimo Taps Katie Szyman

Masimo Taps Katie Szyman as Permanent CEO
Masimo appointed Katie Szyman as its next chief executive officer and named current interim CEO Michelle Brennan as the new chair of the board. The medical technology company on Tuesday said that the executive changes will be effective Feb.
Masimo taps Becton Dickinson executive Katie Szyman as CEO (Jan. 21)
(This Jan. 21 story has been corrected to fix the share price gain to 57% from 45% in paragraph 6) (Reuters) - Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday,
Masimo lands new CEO from BD's patient monitoring division
After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has tapped Katie Szyman for the role, who served as head of Edwards' critical care business,
Masimo picks Katie Szyman as CEO
Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her appointment “fits like a glove,” BTIG analyst Marie Thibault wrote.
Masimo names former Edwards Critical Care leader Katie Szyman as next CEO
Masimo (Nasdaq: MASI) + Masimo Corporation $172.4 1.44% Open 173.198 Day High 175.067 52 Week High 147.89 52 Week Low 75.22 announced today that it appointed Katie Szyman as its new CEO, effective Feb. 12, 2025.
Masimo names Becton Dickinson's Katie Szyman CEO
Masimo said on Tuesday it has named Becton Dickinson executive Katie Szyman as chief executive officer after a bitter proxy battle with activist hedge fund Politan Capital Management led to the ouster of founder Joe Kiani from the medical device maker's board last year.
Masimo names Katie Szyman CEO
Masimo (MASI) announced that Katie Szyman has been appointed the next Chief Executive Officer of the Company. Interim CEO Michelle Brennan has
Business Wire4d
Masimo Announces Leadership Transition
Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...
Needham & Company LLC Reiterates “Hold” Rating for Masimo (NASDAQ:MASI)
Masimo (NASDAQ:MASI – Get Free Report)‘s stock had its “hold” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Wednesday,Benzinga reports.
Cautious Optimism Amid Leadership Change and Strategic Uncertainty at Masimo
Needham analyst Michael Matson has maintained their neutral stance on MASI stock, giving a Hold rating on January 17.Invest with Confidence: ...
MassDevice9d
Masimo expects healthcare sales to grow around 10% in 2025
Looking ahead to 2025, Masimo projects healthcare revenues to land between $1.5 billion and $1.53 billion. That would deliver ...
Reuters5d
Masimo taps Becton Dickinson executive Katie Szyman as CEO
Interim CEO Michelle Brennan, who was backed by the activist investor, was appointed chairman of Masimo's board, and Politan founder Quentin Koffey was named the vice-chairman. The new ...
Piper Sandler Sticks to Its Buy Rating for Masimo (MASI)
Piper Sandler analyst Jason Bednar maintained a Buy rating on Masimo (MASI – Research Report) today and set a price target of $210.00. The ...
Masimo Stock Gains Following Solid Preliminary Q4 Revenues
MASI's revenue growth in the fourth quarter is likely to have been boosted by the continued robust adoption of its products.